Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 38

Results For "ED"

11234 News Found

Dr Jitendra Singh calls for India-led biosimilar insulin scale-up amid global supply concerns
Biotech | April 05, 2026

Dr Jitendra Singh calls for India-led biosimilar insulin scale-up amid global supply concerns

Minister highlights scope for domestic manufacturing during his meeting with Dr Niti Pall, President-elect, International Diabetes Federation


CSIR-CFTRI strengthens food innovation ecosystem with BioNEST launch, 26 startups supported
Startup | April 05, 2026

CSIR-CFTRI strengthens food innovation ecosystem with BioNEST launch, 26 startups supported

Institute signs four MoUs, launches two products and marks 75 years with renewed focus on lab-to-market commercialisation


SRM Prime Hospital's India-first heart procedure saves 73-year-old after standard options fail
Hospitals | April 05, 2026

SRM Prime Hospital's India-first heart procedure saves 73-year-old after standard options fail

The patient, suffering from calcific severe aortic stenosis—a dangerous narrowing of the heart valve caused by calcium buildup—had run out of standard treatment options


Danone India sets record with 20,911 healthcare pledges to fight anemia
Healthcare | April 05, 2026

Danone India sets record with 20,911 healthcare pledges to fight anemia

The record-setting effort stems from Danone India’s nationwide ‘IRON UP!’ campaign


Senores makes bold US push with new federal-focused JV
News | April 05, 2026

Senores makes bold US push with new federal-focused JV

Company leadership is framing the move as transformational.


Sun Pharma flags mixed Fibromun trial results, advances new Phase III study in soft tissue sarcoma
Biotech | April 04, 2026

Sun Pharma flags mixed Fibromun trial results, advances new Phase III study in soft tissue sarcoma

The company has highlighted setbacks in Phase II studies while outlining fresh regulatory and late-stage development plans for Fibromun and Nidlegy


Concord Biotech acquires Celliimune to accelerate DNA-engineered cancer therapies
Biotech | April 04, 2026

Concord Biotech acquires Celliimune to accelerate DNA-engineered cancer therapies

Rs 66 lakh acquisition will support DNA engineering and novel cell-gene therapy alternatives to conventional chemotherapy


Cipla strengthens US respiratory portfolio with final FDA nod for generic Nintedanib
Drug Approval | April 04, 2026

Cipla strengthens US respiratory portfolio with final FDA nod for generic Nintedanib

ANDA approval for 100 mg and 150 mg capsules targeting idiopathic pulmonary fibrosis opens access to a $3.76 billion market in USA


Biocytogen and Sihuan Pharmaceutical forge strategic pact to accelerate antibody-based therapies
R&D | April 03, 2026

Biocytogen and Sihuan Pharmaceutical forge strategic pact to accelerate antibody-based therapies

The agreement will combine Biocytogen’s cutting-edge fully human antibody discovery platform with Sihuan Pharmaceutical’s extensive drug development


Cardinal Health boosts production of cutting-edge cancer therapy ingredient
News | April 03, 2026

Cardinal Health boosts production of cutting-edge cancer therapy ingredient

Ac-225, an alpha-emitting radionuclide, can be paired with molecules designed to selectively target cancer cells.